Cargando…
Serum Cytokeratin 18 as a Potential Early Marker for Chemotherapy Response in Breast Cancer Patients: A Prospective Study
BACKGROUND: Currently, it is well recognized that response to neoadjuvant chemotherapy is an important predictive factor for survival in breast cancer patients. However, it is still an area of research about which patient would respond to the neoadjuvant chemotherapy. METHODS: Serum CK18 levels were...
Autores principales: | Hendawy, Shimaa R, Mansour, Mostafa, Hamed, Manar, Hossam, Amr, Ramez, Ahmed M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
West Asia Organization for Cancer Prevention
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10334074/ https://www.ncbi.nlm.nih.gov/pubmed/36974552 http://dx.doi.org/10.31557/APJCP.2023.24.3.969 |
Ejemplares similares
-
Chemotherapy increases caspase-cleaved cytokeratin 18 in the serum of breast cancer patients
por: Ulukaya, Engin, et al.
Publicado: (2011) -
Changes in Cytokeratin 18 during Neoadjuvant Chemotherapy of Breast Cancer: A Prospective Study
por: Fazilat-Panah, Danial, et al.
Publicado: (2020) -
Serum Cytokeratin 18 as a Metastatic and Therapeutic Marker for Extramammary Paget’s Disease
por: URANO-TAKAOKA, Mariko, et al.
Publicado: (2022) -
Serum Cytokeratin-18 Levels for Liver Fibrosis Prediction
por: Caviglia, Gian Paolo, et al.
Publicado: (2015) -
Stem Cell Markers (Cytokeratin 17 and Cytokeratin 19) in Scarring and Nonscarring Alopecia
por: El Sakka, Dalia, et al.
Publicado: (2016)